As of 2026-03-30, the Relative Valuation of Amgen Inc (AMGN) is 269.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 348.77 USD, the upside of Amgen Inc based on Relative Valuation is -22.6%.
The range of the Relative Valuation is 227.72 - 305.03 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 18.2x | 17.2x |
| Forward P/E multiples | 17.5x - 19.2x | 18.4x |
| Fair Price | 227.72 - 305.03 | 269.84 |
| Upside | -34.7% - -12.5% | -22.6% |
| Date | P/E |
| 2026-03-27 | 24.38 |
| 2026-03-26 | 24.69 |
| 2026-03-25 | 24.74 |
| 2026-03-24 | 24.36 |
| 2026-03-23 | 24.45 |
| 2026-03-20 | 24.31 |
| 2026-03-19 | 24.46 |
| 2026-03-18 | 24.57 |
| 2026-03-17 | 25.25 |
| 2026-03-16 | 25.60 |
| 2026-03-13 | 25.60 |
| 2026-03-12 | 25.71 |
| 2026-03-11 | 26.40 |
| 2026-03-10 | 26.25 |
| 2026-03-09 | 26.35 |
| 2026-03-06 | 25.83 |
| 2026-03-05 | 25.70 |
| 2026-03-04 | 26.51 |
| 2026-03-03 | 26.36 |
| 2026-03-02 | 26.96 |
| 2026-02-27 | 27.14 |
| 2026-02-26 | 26.52 |
| 2026-02-25 | 26.87 |
| 2026-02-24 | 26.77 |
| 2026-02-23 | 26.52 |
| 2026-02-20 | 26.20 |
| 2026-02-19 | 26.25 |
| 2026-02-18 | 26.55 |
| 2026-02-17 | 26.10 |
| 2026-02-13 | 25.81 |
| 2026-02-12 | 25.60 |
| 2026-02-11 | 25.63 |
| 2026-02-10 | 25.49 |
| 2026-02-09 | 26.27 |
| 2026-02-06 | 26.87 |
| 2026-02-05 | 25.71 |
| 2026-02-04 | 25.60 |
| 2026-02-03 | 23.67 |
| 2026-02-02 | 24.10 |
| 2026-01-30 | 23.90 |
| 2026-01-29 | 23.97 |
| 2026-01-28 | 23.92 |
| 2026-01-27 | 24.56 |
| 2026-01-26 | 24.45 |
| 2026-01-23 | 24.10 |
| 2026-01-22 | 24.26 |
| 2026-01-21 | 24.02 |
| 2026-01-20 | 23.14 |
| 2026-01-16 | 23.10 |
| 2026-01-15 | 23.07 |